UBS Group
ZEPP

UBS Group’s Zepp Health ZEPP Stock Holding History

UBS Group’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Sell
34,323
-63,894
-65% -$1.31M ﹤0.01% 6216
2025
Q4 		$2.65M Sell
98,217
-83,085
-46% -$2.96M ﹤0.01% 4694
2025
Q3 		$8.3M Buy
181,302
+180,204
+16,412% +$5.46M ﹤0.01% 3501
2025
Q2 		$2.92K Buy
+1,098
New +$2.81K ﹤0.01% 9403
2024
Q3 		– Sell
-16,860
Closed -$40.5K – 10150
2024
Q2 		$40.5K Buy
16,860
+13,293
+373% +$43.2K ﹤0.01% 6851
2024
Q1 		$14.6K Buy
3,567
+3,479
+3,953% +$17.9K ﹤0.01% 7059
2023
Q4 		$497 Sell
88
-1
-1% -$5 ﹤0.01% 8629
2023
Q3 		$410 Buy
89
+1
+1% +$5 ﹤0.01% 8514
2023
Q2 		$399 Sell
88
-1,704
-95% -$8.59K ﹤0.01% 8256
2023
Q1 		$9.39K Sell
1,792
-743
-29% -$5.26K ﹤0.01% 7661
2022
Q4 		$14.7K Buy
+2,535
New +$13.6K ﹤0.01% 8053
2022
Q1 		– Sell
-1,625
Closed -$33K – 10999
2021
Q4 		$33K Buy
1,625
+1,559
+2,362% +$46.8K ﹤0.01% 7309
2021
Q3 		$2K Sell
66
-11
-14% -$454 ﹤0.01% 9004
2021
Q2 		$4K Sell
77
-533
-87% -$22.2K ﹤0.01% 8703
2021
Q1 		$26K Buy
610
+511
+516% +$29.7K ﹤0.01% 7139
2020
Q4 		$5K Buy
+99
New +$4.94K ﹤0.01% 7855
2020
Q3 		– Sell
-100
Closed -$5K – 8465
2020
Q2 		$5K Sell
100
-43
-30% -$1.98K ﹤0.01% 7395
2020
Q1 		$7K Buy
143
+43
+43% +$2.33K ﹤0.01% 7166
2019
Q4 		$5K Sell
100
-554
-85% -$23.2K ﹤0.01% 7604
2019
Q3 		$26K Buy
654
+383
+141% +$16.1K ﹤0.01% 6583
2019
Q2 		$11K Sell
271
-265
-49% -$11.1K ﹤0.01% 7034
2019
Q1 		$28K Buy
+536
New +$28.9K ﹤0.01% 6013
2018
Q4 		– Sell
-195
Closed -$8K – 8350
2018
Q3 		$8K Buy
+195
New +$7.85K ﹤0.01% 7295
2018
Q2 		– Sell
-145
Closed -$6K – 8305
2018
Q1 		$6K Buy
+145
New +$6.43K ﹤0.01% 7167

Other funds holding ZEPP

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MM
Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

UBS Group's ZEPP Position: Q1 2026 in Review

UBS Group reduced its Zepp Health (ZEPP) stake by 65% in Q1 2026, selling an estimated $1.31M and leaving 34,323 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #6216.

UBS Group first reported a position in ZEPP in Q1 2018 and has held it in 24 quarters since. The position peaked at $8.3M in Q3 2025. 32 funds tracked by Wall St. Rank hold ZEPP as of Q1 2026.

  • UBS Group held 34,323 shares of Zepp Health worth $410K as of Q1 2026.
  • UBS Group sold 63,894 Zepp Health shares in Q1 2026, an estimated $1.31M.
  • Zepp Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6216 holding.
  • UBS Group first reported a position in Zepp Health in Q1 2018 and has held it in 24 quarters since.
  • UBS Group's Zepp Health position peaked at $8.3M in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Zepp Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.